🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Meeting of EQ-5D researchers 20 February 2025 Second meeting of EQ-5D researchers in the UK and Ireland on 20 February 2025 in London. Pls register to participate. surveymonkey.com/r/TNPKZQ2 Conwy Hall, 25 Red Lion St, London WC1R 4RL

Original Article by Tal Ifargan et al.: Autonomous LLM-Driven Research — from Data to Human-Verifiable Research Papers nejm.ai/4f8JAPA #ArtificialIntelligence

🚀 DeepSeek-R1 is here! ⚡ Performance on par with OpenAI-o1 📖 Fully open-source model & technical report 🏆 MIT licensed: Distill & commercialize freely! 🌐 Website & API are live now! Try DeepThink at chat.deepseek.com today! 🐋 1/n

Our last but not least paper about Covid published at BMJ Public Health - re-infection posed greater risk for hospitalization and mortality compared with first-time infection. Prevention is the still the key ⁦CSMPR_HKU⁩ ⁦Vincent Yan⁩ bmjpublichealth.bmj.com/content/3/1/e0…

Teslas now drive themselves from their birthplace at the factory to their designated loading dock lanes without human intervention One step closer to large-scale unsupervised FSD

Happy to have caught up with Carlos KH Wong of HKU Medicine and London School of Hygiene & Tropical Medicine during his visit back to #hongkong. A wonderful collaborator throughout the years. Looking forward to future projects together! #sarcoma #LCSM #costeffectiveness #NGS #realworldevidence CUHK Medicine #CUHKSarcoma

Proud collaboration with Laboratory of Data Discovery for Health leveraging ensemble AI approach with lightweight LLMs for thyroid cancer staging and risk stratification. Excited for the era of AI-enhanced clinical medicine! npj Digital Medicine HKU Surgery Carlos KH Wong Joseph Wu Brian H Lang nature.com/articles/s4174…

1/5 Check out our new paper in npj Digital Medicine! "Continuous multimodal data supply chain and expandable clinical decision support for oncology" Led by our med onc, Sang Joon Shin (PI) and MP Jinsung. rdcu.be/ebxep

Congratulations to our PhD student Matthew SH CHUNG who gave an excellent talk regarding the disease burden in patients with HCC in the APASL-AASLD workshop and won the best presentation award! 🥇 HKU Medicine AASLD APASL News #APASL2025

Today is the start of a new era of natively multimodal AI innovation. Today, we’re introducing the first Llama 4 models: Llama 4 Scout and Llama 4 Maverick — our most advanced models yet and the best in their class for multimodality. Llama 4 Scout • 17B-active-parameter model

In a large trial involving 180 schools in different contexts in China, interactions with a chatbot provided to parents increased uptake and appointments for HPV vaccination, with stronger increases in rural areas. nature.com/articles/s4159…

Our Managing Director Joseph Wu and his team from Laboratory of Data Discovery for Health, HKU Medicine & London School of Hygiene & Tropical Medicine unveil the world’s first AI model to classify both stage & risk category of thyroid cancer, with >90% accuracy, reducing preparation time for clinicians by ~50%.

Press release: shorturl.at/APY8g (HKUMed) / shorturl.at/keMJ8 (HKU) Carlos KH Wong Matrix Fung #AI #Healthcare #ThyroidCancer #Innovation #MedTech #Research

Just out at NEJM - our report with Arnold S. Monto and other collaborators on the CENTERSTONE trial nejm.org/doi/full/10.10… provides the first robust evidence that an influenza antiviral treatment (baloxavir marboxil) can curb the spread of influenza within households. This

Researchers from HKUMed, Laboratory of Data Discovery for Health and London School of Hygiene & Tropical Medicine have unveiled the first artificial intelligence model designed to classify both the cancer stage and risk category of thyroid cancer, achieving impressive accuracy exceeding 90%. For more: hkumed.hk/dbad82

Introducing Qwen3! We release and open-weight Qwen3, our latest large language models, including 2 MoE models and 6 dense models, ranging from 0.6B to 235B. Our flagship model, Qwen3-235B-A22B, achieves competitive results in benchmark evaluations of coding, math, general

New in The BMJ: Gabapentinoid treatment not directly linked to increased self-harm risk. Risk is highest before and after treatment—not during. Close monitoring needed across the full treatment journey. Read more: bmj.com/content/389/bm…

El Mister 💪 #RolandGarros

📢 #Happy to share w/ #LCSM community! After 3+ years of work, we are pleased to share our #cost_effectiveness modelling for #lungcancer 🫁 #screening 🏥📸 in both #high-risk populations determined by both #smoking & #non-smoking risk factors e.g. family history for an entire

Thanks RTHK for giving me the opportunity to #introduce and #discuss #SoftTissue #sarcomas to the wider community. A group of #rarediseases which benefits from #awareness and #specialistcare #sarcomaawarenessmonth #CUHKSarcoma CUHK Medicine CTOS #CTOSTweeTOS